Member Info for EarlofAim

In anticipation of the Government of India's (GoI) ratification of the Acquisition, the Company is advancing the various steps needed to recommence production from two wells (C-73 and C-77H); a further update will follow soon. The Company is also planning to workover and re-complete C-77H to boost production in early 2022.

The development of well programs for two new horizontal wells (C-78 and C-79) is at an advanced stage and the Company has issued a Request for Quotation for well management services for the execution of the two new wells which is planned, subject to securing the necessary funding, for H2 2022.

Rns is very Rampy, CEO knows....

finding required for the c78 - 4 C79

H2 2022

rampy Rns

Health Minister reiterated that Covid is costing NHS and the Economy, This treatment would become norm and people would live and work without the fear of Covid19 mortality.

this will become household name just like Pain killers, Paracetamol.

this will evolve something like this

for painkiller take - Paracetamol/ibuprofen

Covid - this drug AZD1656

hope this makes sense

Excaliburhealth.co.uk
Professor Chris Evans has links to UAE Mubadala (UAE sovereign wealth management fund)

Sp could rise very quickly on the commercial deal.

I reckon next week we should see some update.

GL

WHO have said people with diabetes are more likely to die or get severe covid19, and Vela with Mubadala, UK government and Excalibur health took the initiative to find a Covid treatment for the diabetics patients.

Now that the trial is successful and ongoing commercialisation is expected immediately, suggest Big pharma could be bidding for this.

https://www.who.int/health-topics/diabetes#tab=tab_1

Jimmy

nice post about Health Minister to say this "we have covid19 treatment" this looks like Professor Chris Evans has links to Health department and Covid19 treatment would be sought after.

GL, Vela would be a transformational company in the next few weeks.

Read rns yesterday, didn't think much of it because of the 9 month time frame for evaluation.

well done holders and buyers

look whose involved in this project to treat covid19 patients with Diabetics and non diabetes.

https://www.mubadala.com/en/who-we-are/about-the-company

Professor Sir Chris Evans, chairman and CEO of Excalibur Healthcare Services, the parent company of Excalibur Medicines Ltd., said: "We are hugely encouraged by this data and are delighted to have played our part arranging this trial. I am particularly grateful to His Royal Highness, the Crown Prince of Abu Dhabi, the Mubadala Sovereign Wealth Fund and our own government in supporting this project. We are looking forward to the next chapter in this exciting journey which could ultimately help people who remain vulnerable to COVID-19."

UAE sheikh had meeting with PM Boris Johnson to Mubadala is UAE sovereign wealth fund investor. Meaning Mubadala Invests on behalf of the UAE government.

Professor Chris Evans has good links with UAE Sheikhs and he is the Chairman of Excalibur Healthcare Services.

UK government also supports this Project - treatment for Covid-19 patients, especially with Diabetics patients.
GLA and Dyor

September 15, 2021 9:30 pm by Andrew England in London and Simeon Kerr in Dubai
The United Arab Emirates is to announce a big increase in investment in the UK as the oil-rich Gulf state expands a multibillion-pound partnership with the British government.

Emirati and British officials will sign an agreement on Thursday that will commit the UAE to investing in UK infrastructure, clean energy and technology. A government official briefed on the talks said the UAE’s overall investment commitment over five years would be about £10bn.

That would be double the amount expected when the UK and UAE announced a five-year “sovereign investment partnership” in March, with an initial pledge that Mubadala, Abu Dhabi’s state fund, would invest £800m in the UK’s life sciences sector.

UAE sheikh met with Boris,

https://www.ft.com/content/8f1ed55f-2bc6-47b4-95f7-85e4ac11af41

Affordable British-made Covid drug could slash mortality rates
A tablet lingering in AstraZeneca's unused drugs library shows promising results treating diabetic Covid patients

17 February 2021 • 4:41pm
A drug being trialled in the UK appears to dramatically cut death rates in diabetics suffering from Covid, sources have said, in a potential further boost for the fight against the disease....

The Accountant

Well done on your Accounting Skills, sellers out completely.
I've done my own accounting and can say what you've found.

Let the proper re rate commence from Tomorrow.

chart has this on 0.15p, then 0.38p

On the commercial deal announcement these will be history

GLA and Dyor this company will become very successful soon

The Accountant

Well done on your Accounting Skills, sellers out completely.
I've done my own accounting and can say what you've found.

Let the proper re rate commence from Tomorrow.

chart has this on 0.15p, then 0.38p

On the commercial deal announcement these will be history

GLA and Dyor this company will become very successful soon

Mannan

This should take off tomorrow as last of the sell printed now and after hours.
keep this in mind "AstraZeneca"

As for investors need to help understand the RNS, it will be best to explain to those who can't comprehend what Rns is about without the abuse.

we all need help now and again as we can't research all the company news.

GLA

could this be, because of some delay in the project, Glencore the villian here?

that UT, dropped the Sp, however in reality its the same. just mislead by Market makers.

funny algorithm set up to dupe investors to sell.

Looks like Mms fishing for stocks

weathergeek

fantastic research on the broker note, I did know this but forgot to put on the chat
So ATM even without the helium Mosman is trading at heavy discount.